Sunday, March 23, 2014 12:07:09 AM
The question is, will they actually achieve such? If the science behind 485 is real and true, well, then it's only a matter of time until this thing rockets. There's no way a major drug company would not want to swipe this up and who knows what they'd pay.
If the science is murky well, it may just build slowly or stagnate. But I'm thinking that things will probably work out in its favor.
I don't think that there'll be any problem getting the patent issued. It'll just take some time. But getting a patent issued is not as important as getting the "drug" approved. Surely getting the patent issued would boost the stock even more, but when the "drug" gets approved, phew, this thing will do a Gleason (Bang, Zoom!!)
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM